Mitolux™ is Glowmeda’s core platform for supporting metabolic health, specifically targeting mitochondrial function to improve insulin sensitivity. It uses low-intensity, narrow-spectrum light in the 620–860nm range to stimulate mitochondrial membrane potential and activate oxidative phosphorylation — key processes in glucose metabolism. By restoring energy efficiency at the cellular level, Mitolux™ helps regulate blood sugar and reduce insulin resistance. This non-invasive, drug-free approach offers new possibilities for managing type 2 diabetes and other metabolic disorders. Mitolux™ technology powers Glowmeda’s metabolic product line, and has demonstrated promising effects in preclinical studies focused on chronic metabolic dysfunction.

Solvanta™ is designed to enhance cellular energy production and tissue repair, making it especially effective for addressing post-COVID symptoms such as fatigue, insomnia, and brain fog. Utilizing low-intensity light in the 650–850nm range, Solvanta™ stimulates mitochondrial ATP production — the energy currency of the cell — helping cells recover from oxidative stress and inflammation. This platform supports both the nervous and immune systems, promoting holistic recovery from long COVID and other chronic fatigue conditions. Integrated into Glowmeda’s energy restoration products, Solvanta™ delivers gentle yet sustained support for individuals navigating prolonged post-viral symptoms.

Ceralux Pro™ is Glowmeda’s proprietary platform for neurocognitive health and memory support. Using low-intensity near-infrared light in the 820–850nm range, it penetrates the scalp and skull to reach deep brain structures, particularly the hippocampus. This wavelength range has been shown to boost mitochondrial activity in brain tissue, enhance cerebral blood flow, and increase expression of brain-derived neurotrophic factor (BDNF). These effects contribute to improved memory, focus, and neuroplasticity — with potential applications in the early intervention of Alzheimer’s disease. Ceralux Pro™ is embedded in Glowmeda’s brain health product line, offering safe, non-invasive support for aging brains and cognitive decline.

MIRA™ combines multiple low-intensity wavelengths (450–850nm) to target skin regeneration, inflammation, and aging. Blue light (450–490nm) provides antimicrobial and anti-inflammatory benefits, ideal for acne-prone or sensitive skin. Red light (620–660nm) promotes epidermal repair, while near-infrared light (800–850nm) penetrates into the dermis to stimulate collagen and elastin production. Together, these wavelengths form a layered, synergistic system that supports skin repair and rejuvenation at multiple depths. MIRA™ is the foundation of Glowmeda’s skincare and dermal wellness products, designed to combine everyday self-care with clinical-grade effects — naturally supporting skin health from the inside out.